|
π
|
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
182 auth.
O. Kondrashova,
M. Topp,
K. NeΕ‘iΔ,
Elizabeth Lieschke,
G. Ho,
M. Harrell,
Giada V. Zapparoli,
A. Hadley,
Robert Holian,
Emma Boehm,
V. Heong,
E. Sanij,
R. Pearson,
J. Krais,
N. Johnson,
...
O. Mcnally,
S. Ananda,
K. Alsop,
Karla J. Hutt,
S. Kaufmann,
K. Lin,
T. Harding,
N. Traficante,
G. Chenevix-Trench,
A. Green,
P. Webb,
D. Gertig,
S. Fereday,
S. Moore,
J. Hung,
K. Harrap,
T. Sadkowsky,
N. Pandeya,
M. Malt,
A. Mellon,
R. Robertson,
T. Vanden Bergh,
M. Jones,
P. Mackenzie,
J. Maidens,
K. Nattress,
Y. Chiew,
A. Stenlake,
H. Sullivan,
B. Alexander,
P. Ashover,
S. Brown,
T. Corrish,
L. Green,
L. Jackman,
K. ferguson,
K. Martin,
A. Martyn,
B. Ranieri,
J. White,
V. Jayde,
P. Mamers,
L. Bowes,
L. Galletta,
D. Giles,
J. Hendley,
T. Schmidt,
H. Shirley,
C. Ball,
C. Young,
S. Viduka,
H. Tran,
S. BiliΔ,
L. Glavinas,
J. Brooks,
R. Stuart-Harris,
F. Kirsten,
J. Rutovitz,
P. Clingan,
A. Glasgow,
A. Proietto,
S. Braye,
G. Otton,
J. Shannon,
T. Bonaventura,
J. Stewart,
S. Begbie,
M. Friedlander,
D. Bell,
S. Baron-Hay,
A. Ferrier,
G. Gard,
D. Nevell,
N. Pavlakis,
S. Valmadre,
B. Young,
C. Camaris,
R. Crouch,
L. Edwards,
N. Hacker,
D. Marsden,
G. Robertson,
P. Beale,
J. Beith,
J. Carter,
C. Dalrymple,
R. Houghton,
P. Russell,
M. Links,
J. Grygiel,
J. Hill,
A. Brand,
K. Byth,
R. Jaworski,
P. Harnett,
R. Sharma,
G. Wain,
B. Ward,
D. Papadimos,
A. Crandon,
M. Cummings,
K. Horwood,
A. Obermair,
L. Perrin,
D. Wyld,
J. Nicklin,
M. Davy,
M. Oehler,
C. Hall,
T. Dodd,
T. Healy,
K. Pittman,
D. Henderson,
J. Miller,
J. Pierdes,
P. Blomfield,
D. Challis,
R. McIntosh,
A. Parker,
B. Brown,
R. Rome,
D. Allen,
P. Grant,
S. Hyde,
R. Laurie,
M. Robbie,
D. Healy,
T. Jobling,
T. Manolitsas,
J. McNealage,
P. Rogers,
B. Susil,
E. Sumithran,
I. Simpson,
K. Phillips,
D. Rischin,
S. Fox,
D. Johnson,
S. Lade,
M. Loughrey,
N. OβCallaghan,
W. Murray,
P. Waring,
V. Billson,
J. Pyman,
D. Neesham,
M. Quinn,
C. Underhill,
R. Bell,
L. Ng,
R. Blum,
V. Ganju,
I. Hammond,
Y. Leung,
A. McCartney,
M. Buck,
I. Haviv,
D. Purdie,
D. Whiteman,
N. Zeps,
A. Defazio,
I. McNeish,
D. Bowtell,
E. Swisher,
A. Dobrovic,
M. Wakefield,
C. Scott
|
7 |
2018 |
7
π
|
|
π¦
|
Molecular correlates of platinum response in human highβgrade serous ovarian cancer patientβderived xenografts
22 auth.
M. Topp,
L. Hartley,
Michele Cook,
V. Heong,
Emma Boehm,
Lauren Mcshane,
J. Pyman,
O. Mcnally,
S. Ananda,
Marisol Harrell,
...
D. Etemadmoghadam,
L. Galletta,
K. Alsop,
G. Mitchell,
S. Fox,
J. Kerr,
Karla J. Hutt,
S. Kaufmann,
E. Swisher,
D. Bowtell,
M. Wakefield,
C. Scott
|
7 |
2014 |
7
π¦
|
|
π
|
A community-based model of rapid autopsy in end-stage cancer patients
62 auth.
K. Alsop,
Heather Thorne,
S. Sandhu,
A. Hamilton,
Christopher P. Mintoff,
E. Christie,
O. Spruyt,
S. Williams,
O. Mcnally,
L. Mileshkin,
S. Ananda,
Julene Hallo,
S. Loi,
C. Scott,
P. Savas,
...
L. Devereux,
Patricia OβBrien,
S. Gunawardena,
C. Hampson,
Kate Strachan,
R. D. Jaravaza,
V. Francis,
Gregory Young,
D. Ranson,
R. Samaranayake,
David Stevens,
Samantha E. Boyle,
C. Fedele,
M. Topp,
G. Ho,
Z. L. Teo,
Renea A. Taylor,
M. Papargiris,
M. Lawrence,
Hong Wang,
G. Risbridger,
N. Haynes,
Mikolaj Medon,
R. Johnstone,
Eva Vidacs,
Gisela Mir Arnau,
I. Vergara,
A. Papenfuss,
G. McArthur,
P. Waring,
Shirley Carvosso,
C. Angel,
D. Gyorki,
B. Solomon,
G. Mitchell,
S. Shanley,
P. Francis,
S. Dawson,
A. Haffenden,
Erin Tidball,
M. Volchek,
J. Pyman,
M. Madadin,
Jodie Leditschke,
S. Cordner,
M. Shackleton,
D. Bowtell
|
6 |
2016 |
6
π
|
|
π
|
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
25 auth.
M. Hoppe,
P. Jaynes,
J. Wardyn,
S. S. Upadhyayula,
T. Tan,
S. Lie,
D. Lim,
B. Pang,
Sherlly Lim,
Joe P S Yeong,
A. Karnezis,
D. Chiu,
S. Leung,
D. Huntsman,
Anna S. Sedukhina,
...
Ko Sato,
M. Topp,
C. Scott,
Hyungwon Choi,
N. Patel,
Robert Brown,
S. Kaye,
Jason J Pitt,
D. Tan,
A. Jeyasekharan
|
5 |
2021 |
5
π
|
|
π
|
PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION IN UNTREATED DLBCL: RESULTS FROM THE PHASE III GOYA STUDY
19 auth.
L. Sehn,
M. Oestergaard,
M. TrnΔnΓ½,
A. Bosi,
M. Egyed,
Γ. IllΓ©s,
H. Nakamae,
Stephen Samuel Opat,
M. Topp,
F. Zaja,
...
G. Fingerle-Rowson,
G. Lei,
T. Nielsen,
E. Punnoose,
M. Rahman,
J. Ray,
L. Zhang,
M. Martelli,
U. Vitolo
|
4 |
2017 |
4
π
|
|
π
|
ABCC4/MRP4 contributes to the aggressiveness of Mycβassociated epithelial ovarian cancer
21 auth.
MoonSun Jung,
Jixuan Gao,
L. Cheung,
Angelika Bongers,
K. Somers,
M. Clifton,
Emma E. Ramsay,
A. Russell,
E. Valli,
A. Gifford,
...
J. George,
C. Kennedy,
M. Wakefield,
M. Topp,
G. Ho,
C. Scott,
D. Bowtell,
A. De Fazio,
M. Norris,
M. Haber,
M. Henderson
|
3 |
2020 |
3
π
|
|
π
|
Oxidative phosphorylation diseases and cerebellar ataxia.
7 auth.
J. Shoffner,
A. Kaufman,
D. Koontz,
N. Krawiecki,
E. Smith,
M. Topp,
...
D. Wallace
|
3 |
1995 |
3
π
|
|
π¬
|
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer
A. Inderjeeth,
M. Topp,
E. Sanij,
E. Castro,
S. Sandhu
|
2 |
2022 |
2
π¬
|
|
π
|
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
29 auth.
S. Trinder,
C. McKay,
Phoebe Power,
M. Topp,
Bosco Chan,
Santosh Valvi,
G. McCowage,
Dinisha Govender,
M. Kirby,
D. Ziegler,
Neevika Manoharan,
T. Hassall,
S. Kellie,
John J. Heath,
F. Alvaro,
...
P. Wood,
S. Laughton,
K. Tsui,
A. Dodgshun,
D. Eisenstat,
R. Endersby,
S. Luen,
E. Koh,
H. Sim,
B. Kong,
N. Gottardo,
James R. Whittle,
Dong-Anh Khuong-Quang,
J. Hansford
|
2 |
2023 |
2
π
|
